Tag: Canonpharma

Canonpharma is Russian pharmaceutical company. CJSC “Canonpharma production” was founded in September 1998. In a relatively short period of time company managed to create a modern industrial base. The first step was the development was the opening of the tablet dosage forms packing site with an annual capacity of 40 million blisters.
The production facility for the production of finished dosage forms was put into operation in 2004 in Schelkovo, Moscow region.
CJSC “Canonpharma production” is a high-tech full-cycle production, designed, constructed and equipped in accordance with the requirements of GMP. Manufacturability and equipment production is increasing every year. In September 2007 company completed the installation and commissioning of new automatic production line. After the production launched the capacity increased to 80 million units per year.
Company’s portfolio of cardiovascular agents offers such high-demand pharmaceuticals as Deprenorm®MV (prolonged release trimetazidine), CardiASK® (acetylsalicylic acid), Aritel® (bisoprolol), Aritel®Plus (bisoprolol and hydrochlorothiazide), Fosinap® (fosinopril), Warfarin, Clopidogrel, Felodipine, Indapamide retard, Amlodipine, Atorvastatin etc. Our neurological products include Vinpotropile® (vinpocetine and piracetam), Thiolepta® (thioctic acid), Mexi B6® (ethylmethylhydroxypyridine succinate + pyridoxine), Glycine-Canon, Gabapentin and Betahistine. Canonpharma Production is also a manufacturer of gastroenterological agents represented by Phosphonciale® (phospholipids and flavonoids of Silybum marianum), Sparex® (mebeverine), Cansalazine® (mesalazine) and Exhol® (ursodeoxycholic acid).

No posts to display